20973 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-10
INTERCALATING SUGAR MOLECULES
#2THERAPIES FOR NEUROMUSCULOSKELETAL INJURIES AND LIMB TRANSPLANTATION
#3MEGAKARYOCYTE DERIVATIVES FOR TREATMENT OF DRY EYE DISEASES
#4System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein
#5USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS
#6ALPHAVIRUS T CELL EPITOPES, MEGAPOOLS AND USES THEREOF
#7COMPOSITIONS AND METHODS FOR FACILITATING HEART AND LUNG REPAIR
#8CONTROLLED EXPRESSION OF A TRANSGENE IN HUMAN T OR NK CELLS FOR USE IN CELLULAR IMMUNOTHERAPY
#9METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND AUTOIMMUNE CONDITIONS WITH ECM-AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS
#10COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE
#11IL-10-Producing CD4+ T Cells and Uses Thereof
#12COMBINATION ANTI-4-1BB IMMUNOTHERAPY, RADIOTHERAPY, AND B CELL ACTIVATION THERAPY
#13COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS
#14ENGINEERED BACTERIAL THERAPEUTICS FOR THE TREATMENT OF GASTROINTESTINAL DISEASE
#15IL10 AGONISTS AND METHODS OF USE THEREOF
#16METHOD FOR INDUCING TISSUE REGENERATION AND TREATING AUTOIMMUNE DISEASES USING MESENCHYMAL STEM CELLS
#17COMPOSITIONS COMPRISING AN INTERLEUKIN CONSTRUCT
#18COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES
#19DELIVERY SYSTEM USING ENGINEERED EXTRACELLULAR VESICLES
#20CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#21BACTERIAL BIOSENSORS FOR DIAGNOSING AND TREATING INFLAMMATION
#22CHIMERIC IL-10/CARRIER CONSTRUCTS FOR TREATMENT OF POUCHITIS AND METHODS OF USE
#23CD4+ T CELLS EXPRESSING IL-10 AND CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#24BTNL3/8 TARGETING CONSTRUCTS FOR DELIVERY OF PAYLOADS TO THE GASTROINTESTINAL SYSTEM
#25CD4+ T CELLS EXPRESSING IL-10 AND CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#26COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION AND CANCER
#27METHODS OF TREATING OR PREVENTING PREMATURE OVARIAN INSUFFICIENCY, POLYCYSTIC OVARY SYNDROME, OR INFERTILITY USING EXOSOMES OR MESENCHYMAL STEM CELLS
#28USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS
#29IL-10 Monomer Fusion Protein and Use thereof
#30PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS
#31GENETICALLY MODIFIED MICROORGANISM AND USE THEREOF
#32METHODS AND COMPOUNDS FOR THE TREATMENT OR PREVENTION OF SEVERE INFLUENZA
#33BIOCOMPATIBLE DEVICES FOR CELL-BASED THERAPIES AND RELATED METHODS
#34IL-10 Expressing Cells For Enhanced Cancer Immunotherapies
#35INTERLEUKIN-10 MUTEINS AND FUSION PROTEINS THEREOF
#36COMPOSITIONS AND METHODS FOR MACROPHAGE CONVERSION
#37COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#38METHODS AND COMPOSITIONS TO ENHANCE THE ANTI-INFLAMMATORY EFFECTS OF INTERLEUKIN 10
#39METHODS OF USING SPLICING MODULATORS
#40USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS
#41COMPOSITIONS AND METHODS FOR TREATING ALLERGIES AND INFLAMMATORY CONDITIONS
#42BACTERIAL TARGETING VECTOR CARRYING CYTOKINE OR POLYNUCLEOTIDE THEREOF AND USE THEREOF IN TUMOR TREATMENT
#43METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#44CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#45ENHANCED EFFICACY OF TOLEROGENIC VACCINATION
#46PERSONALIZED IMMUNOTHERAPY USING INTESTINAL METABOLITES
#47CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#48METHODS AND MATERIALS FOR TREATING A STROKE
#49CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#50BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER
#51COMPOSITIONS AND METHODS OF USE OF INTERLEUKIN-10 IN COMBINATION WITH IMMUNE CHECK-POINT PATHWAY INHIBITORS
#52Skin Probiotics
#53METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#54NOVEL ENGINEERED CAPSID SEROTYPE OF RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR WITH ENHANCED TRANSDUCTION EFFICIENCY AND WIDESPREAD DISTRIBUTION IN THE BRAIN
#55METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PROGENITOR CELLS IN VIVO
#56EXOSOME ENCODED IL-10 AS A TREATMENT FOR INFLAMMATION ASSOCIATED ADVERSE PREGNANCY CONDITION
#57MODIFIED IMMUNE CELLS FOR FIBROSIS AND INFLAMMATION
#58CERTAIN ARYL PLADIENOLIDE COMPOUNDS AND METHODS OF USE
#59Coronavirus T Cell Epitopes and Uses Thereof
#60Treatment delivery system and method
#61IL10 agonists and methods of use thereof
#62MONOCYTES INDUCING ANTIGEN-SPECIFIC TOLERANCE, ENGINEERED MONOCYTES, AND METHOD OF USE THEREOF
#63STEM CELLS FOR TRANSPLANTATION AND MANUFACTURING METHOD THEREFOR
#64STEM CELL-DERIVED EXOSOMES CONTAINING PAIN REGULATORS, AND USES THEREOF
#65PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS
#66USE OF DUAL CYTOKINE FUSION PROTEINS COMPRISING IL-10 AND ADOPTIVE CELL THERAPIES OR BISPECIFIC T-CELL ENGAGERS TO TREAT CANCER
#67PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS
#68METHODS FOR THE TREATMENT OF INFLAMMATORY JOINT DISEASE
#69IL-10 AND USES THEREOF
#70MESENCHYMAL STEM CELLS AND USES THEREFOR
#71Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#72BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER
#73ANTIBODY AGAINST CLAUDIN 18A2 AND USE THEREOF
#74Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#75IL-10/fc Fusion Proteins Useful As Enhancers Of Immunotherapies
#76COMPOSITION FOR TREATING PAIN
#77EXTENDED RELEASE IMMUNOMODULATORY IMPLANT TO FACILITATE BONE MORPHOGENESIS
#78METHODS FOR THE TREATMENT OF INFLAMMATORY JOINT DISEASE
#79Methods and compounds for the treatment or prevention of severe influenza
#80METHOD OF INDUCING ANTIGEN-SPECIFIC TOLERANCE IN A SUBJECT BY ADMINISTERING A COMPOSITION COMPRISING AN APOPTOTIC BODY SURROGATE AND COUPLED IMMUNODOMINANT ANTIGENIC EPITOPES ASSOCIATED WITH AUTOIMMUNE DISEASE
#81Interleukin 10 Conjugates and Uses Thereof
#82Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#83NOVEL FUSION PROTEIN AND USE OF SAME
#84CELL CULTURE FOR TREATING DISEASE IN THE LOWER LIMBS
#85FORMULATION AND TREATMENT FOR OPHTHALMIC DISORDERS
#86CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#87Platform for generating safe cell therapeutics
#88Platform for generating safe cell therapeutics
#89ANTIBODY CYTOKINE ENGRAFTED COMPOSITIONS AND METHODS OF USE FOR IMMUNOREGULATION
#90METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND AUTOIMMUNE CONDITIONS WITH ECM-AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS
#91EXTENDED RELEASE IMMUNOMODULATORY IMPLANT TO FACILITATE BONE MORPHOGENESIS
#92PLASMA POLYMER NANOPARTICLES CARRYING AGENTS
#93USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS
#94Methods and reagents for modulating macrophage phenotype
#95Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
#96Compositions and methods for macrophage conversion
#97IL10 agonists and methods of use thereof
#98Methods of using splicing modulators
#99METHODS OF TREATING AN AUTOIMMUNE DISEASE
#100IL-10 INHIBITION FOR VACCINES AND IMMUNOTHERAPY
#101Methods and compositions for treating autoimmune and inflammatory conditions
#102Complex coacervate for controlled release and related methods
#103COMPOSITION FOR PREVENTING OR TREATING PULMONARY FIBROSIS CONTAINING EXOSOME ISOLATED FROM ADIPOSE-DERIVED STEM CELL AS ACTIVE INGREDIENT
#104COMPOSITIONS COMPRISING AN INTERLEUKIN CONSTRUCT
#105BTNL3/8 targeting constructs for delivery of payloads
#106Antibodies that bind interleukin-10 receptor-2 peptides, compositions, and methods of use thereof
#107Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#108CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#109Platform for generating safe cell therapeutics
#110Cholix-derived carriers for oral delivery of heterologous payload
#111SINGLE CHAIN Fc FUSION PROTEINS
#112Certain aryl pladienolide compounds and methods of use
#113THREE DIMENSIONAL CLUSTERS OF TRANSDIFFERENTIATED CELLS, COMPOSITIONS AND METHODS THEREOF
#114Microparticle systems and their use for the treatment of multiple sclerosis
#115Platform for generating safe cell therapeutics
#116Methods for treating cardiac conditions
#117Treatment of a disease of the gastrointestinal tract with IL-10 or an IL-10 agonist
#118BIO-MIMETIC FORMULATION
#119Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tighten Gut Mucosal Barrier
#120Compositions and methods for treating inflammation and cancer
#121Compositions for stabilizing and delivering proteins
#122Platform for generating safe cell therapeutics
#123Mesenchymal stem cells and uses therefor
#124Stem cell material, compositions, and methods of use
#125COMPOSITIONS AND METHODS OF USE OF INTERLEUKIN-10 IN COMBINATION WITH IMMUNE CHECK-POINT PATHWAY INHIBITORS
#126METHOD OF TREATING A METABOLIC DISORDER OF THE LIVER
#127System and method for analyzing media for talent discovery
#128Extended release immunomodulatory implant to facilitate bone morphogenesis
#129System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein
#130Extended release immunomodulatory implant to facilitate bone morphogenesis
#131Catalyst for the regeneration of tissues and related method for making it
#132Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#133Mesenchymal stem cells and uses therefor
#134STEM CELLS FOR TRANSPLANTATION AND MANUFACTURING METHOD THEREFOR
#135Platform for generating safe cell therapeutics
#136A TRIPLE-EFFECT COCKTAIL PRODUCED BY NEURAL STEM CELLS AS A NOVEL NEUROREPAIR THERAPY FOR CHRONIC STAGE CNS AUTOIMMUNITY
#137Use of encapsulated cell therapy for treatment of ophthalmic disorders
#138THERAPEUTIC AGENT FOR DILATED CARDIOMYOPATHY
#139NANOVESICLES PRODUCED FROM MESENCHYMAL STROMAL CELLS FOR ANTI-INFLAMMATORY APPLICATIONS
#140Fusion protein comprising IL-4 and IL-10
#141BLOOD SERUM FOR USE IN THE TREATMENT OF NEURODEGENERATIVE OPHTHALMOLOGICAL PATHOLOGIES
#142METHODS FOR THE TREATMENT OF INFLAMMATORY JOINT DISEASE
#143IMMUNOMODULATING CELL CIRCUITS
#144Compositions and Methods for Antigen-Specific Tolerance
#145Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#146COMPOSITIONS AND METHODS FOR TREATING CUTANEOUS CONDITIONS
#147Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
#148Compositions and methods for oral delivery of therapeutic cargo
#149Compositions and methods for oral delivery of therapeutic cargo
#150Methods and compounds for the treatment or prevention of severe influenza
#151Compositions and methods for modulating IL-10 immunostimulatory and anti-inflammatory properties
#152Compositions for in vivo Expression of Therapeutic Sequences in the Microbiome
#153METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS
#154METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS
#155Methods and reagents for modulating macrophage phenotype
#156Methods and compositions for reducing cardiac damage and other conditions
#157COMPOSITION FOR ALLEVIATING OR TREATING PAIN
#158Mesenchymal stem cells expressing anti-inflammatory cytokines and methods of use
#159Methods of treating immune related disorders using antibody-cytokine engrafted compositions
#160Mesenchymal stem cells and uses therefor
#161BIO-MIMETIC FORMULATION
#162Mesenchymal stem cells and uses therefor
#163Mesenchymal stem cells and uses therefor
#164ANTI-CANCER USE OF GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS (HUCPVC)
#165Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#166Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#167Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#168METHODS AND COMPOSITIONS TO ENHANCE THE ANTI-INFLAMMATORY EFFECTS OF INTERLEUKIN 10
#169Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#170Method for delivery of biological molecule to nervous tissue
#171METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS
#172Interleukin-10 receptor-2 peptides, antibodies, compositions, and methods of use thereof
#173Skin probiotic formulation
#174Methods of treating cancer metastasis by using interleukin-10
#175Sustained release formulation of interleukin-10 for wound treatment and related methods
#176Methods for inducing macrophage conversion in a wound
#177Interleukin-10 production of antigen-specific CD8+ T cells and methods of use of same
#178Methods of using combinations of PEG-IL-10 and IL-15 for treating cancers
#179System and method for treating inflammation
#180BACTERIA ENGINEERED TO TREAT METABOLIC DISEASES
#181Placental tissue composition for for treating cardiac tissue damage
#182Methods of Using Interleukin-10 for Treating Diseases and Disorders
#183Complex coacervate for controlled release and related methods
#184TELOMERE EXTENSION AND ANTI-INFLAMMATORY AGENTS FOR CELL REGENERATION
#185METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS
#186STEM CELLS FOR TRANSPLANTATION AND MANUFACTURING METHOD THEREFOR
#187STEM CELLS FOR TRANSPLANTATION AND MANUFACTURING METHOD THEREFOR
#188PHARMACEUTICAL COMPOSITION INCLUDING IL-10-EXPRESSING NEURAL STEM CELLS FOR TREATING CENTRAL NERVOUS SYSTEM DISEASE OR INJURY AND TREATMENT METHOD USING THE SAME
#189Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
#190Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis
#191Single chain Fc fusion proteins
#192Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tighten Gut Mucosal Barrier
#193Composition for treating pain
#194Methods of using interleukin-10 for treating solid tumors
#195Pegylated interleukin-10
#196COMPOSITIONS AND METHODS FOR TREATING MELANOMA
#197PROTOZOAN VARIANT-SPECIFIC SURFACE PROTEINS (VSP) AS CARRIERS FOR ORAL DRUG DELIVERY
#198Transdermal administration of antioxidant for treatment of pain and inflammation
#199Method of modulating a chimeric antigen receptor t cell immune response by administering IL-10
#200System and method for analyzing media for talent discovery
#201Compositions and methods for treating cutaneous conditions
#202COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#203Nanoparticle-Based Antigen Specific Immunotherapy
#204METHODS AND ASSAYS RELATING TO MACROPHAGE DIFFERENTIATION
#205COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#206Lymph node-targeting nanoparticles
#207Methods of treatment with a fusion protein comprising IL-4 and IL-10
#208Methods for treatment of cancer with therapeutic combinations comprising PEG-IL-10
#209Use of encapsulated cell therapy for treatment of ophthalmic disorders
#210IL-10-PRODUCING CD4+ T CELLS AND USES THEREOF
#211Anti-ED-A immunoconjugates for inflammatory bowel disease
#212Use of MicroRNA 375 in Augmenting Stem Cell Based and Endogenous Ischemic Tissue Repair
#213Method of treating cancer with IL-10 and antibodies that induce ADCC
#214Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease
#215Compositions for modulating IL-10 immunostimulatory and anti-inflammatory properties
#216PROBIOTIC ORGANISMS FOR DIAGNOSIS, MONITORING, AND TREATMENT OF INFLAMMATORY BOWEL DISEASE
#217Cytokine-based fusion proteins for treatment of immune disorders
#218Methods of lowering serum cholesterol
#219Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#220Compositions for stabilizing and delivering proteins
#221Methods of using interleukin-10 for treating diseases and disorders
#222Human amniotic fluid preparation having long-term stability
#223Conditioned medium obtained from placental mesenchymal stem cells and use thereof in the therapeutic treatment of preeclampsia
#224Nanoparticles and methods of use
#225Mono- and di-PEG IL-10 production; and uses
#226Antibody cytokine engrafted compositions and methods of use for immunoregulation
#227Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#228ENGINEERED BACTEROIDES OUTER MEMBRANE VESICLES
#229Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent
#230Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
#231BIOTIN-AVIDIN CONTROLLED DELIVERY SYSTEMS
#232Methods and compositions for treating autoimmune and inflammatory conditions
#233Induction of mucosal tolerance to antigens
#234Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors
#235Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
#236HPV vaccines and methods of use thereof
#237Breast cancer vaccines and methods of use thereof
#238Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection
#239Methods of Using Interleukin-10 for Treating Diseases and Disorders
#240Compositions for in vivo expression of therapeutic sequences in the microbiome
#241Use of pegylated IL-10 to treat cancer
#242Methods of Using Interleukin-10 for Treating Diseases and Disorders
#243Use of encapsulated cell therapy for treatment of ophthalmic disorders
#244Compositions and methods for macrophage conversion
#245Combination Treatments and Compositions for Wound Healing
#246INCLUSION BODIES FOR TRANSDERMAL DELIVERY OF THERAPEUTIC AND COSMETIC AGENTS
#247Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
#248Methods of using interleukin-10 for treating diseases and disorders
#249Methods for the treatment of inflammatory joint disease
#250Inhibitors of endoglin activity for the treatment of fibrosis
#251USE OF INTERLEUKIN 10 MRNA TRANSFECTED MACROPHAGES IN ANTI-INFLAMMATORY THERAPIES
#252MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) PROMOTER POLYMORPHISM IN INFLAMMATORY DISEASE
#253SCAFFOLDS CONTAINING CYTOKINES FOR TISSUE ENGINEERING
#254Mono- and di-peg IL-10 production; and uses
#255Methods of using pegylated interleukin-10 for treating hyperlipidemia
#256SINGLE CHAIN FC FUSION PROTEINS
#257Pegylated interleukin-10
#258Treatment of graft-versus-host disease
#259Methods of treating biofilm infections comprising administering inhibitors of myeloid-derived suppressor cells
#260Method for producing autologous proteins
#261TARGETING TYPE I NKT CELLS TO CONTROL INFLAMMATION
#262Pharmacogenomic Biomarkers for B Cell Malignancies and Methods of Use Thereof
#263STEM CELLS FOR TRANSPLANTATION AND MANUFACTURING METHOD THEREFOR
#264Interleukin-10 Compositions and Uses Thereof
#265Methods of using pegylated interleukin-10 for treating cancer
#266Methods of controlling parasitic worms in animals
#267Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis
#268Dermal micro-organs, methods and apparatuses for producing and using the same
#269Anti-ED-A immunoconjugates for inflammatory bowel disease
#270Methods of reducing in poultry
#271METHODS AND ASSAYS RELATING TO MACROPHAGE DIFFERENTIATION
#272METHODS FOR TREATING CARDIAC CONDITIONS
#273Immunomodulating compositions and uses therefor
#274Preeclamptic placental mesenchymal stem cell conditioned medium for use in the treatment of a tumour
#275Methods for treating cardiac conditions
#276Stabilizing shear-thinning hydrogels
#277Compositions and methods for preventing cardiac arrhythmia
#278Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
#279Compositions and methods for preventing cardiac arrhythmia
#280Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery
#281STRESS-REGULATED PROKARYOTIC EXPRESSION CASSETTES
#282Cytokine-based fusion proteins for treatment of immune disorders
#283Mono- and di-PEG IL-10 production; and uses
#284Method of treatment of lymphoma with pegylated IL-10
#285Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same
#286Embryo implantation
#287COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#288Method of reducing scar formation in healing of dermal wounds by administering interleukin-10 and hyaluronan
#289METHODS OF REDUCING SALMONELLA IN POULTRY
#290Method of treating food allergies by administering a nanoparticle comprising heparin and chitosan encapsulating IL-12
#291Methods for treating cardiac conditions
#292Mesenchymal stem cells and uses therefor
#293CONDITIONED MEDIUM OBTAINED FROM PLACENTAL MESENCHYMAL STEM CELLS AND USE THEREOF IN THE THERAPEUTIC TREATMENT OF PREECLAMPSIA
#294Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors
#295Composition for controlled release of physiologically active substance
#296Sterilized and decellularized extracellular matrix for treating cardiac arrhythmia
#297ADOPTIVE CELL THERAPY WITH SPECIFIC REGULATORY LYMPHOCYTES
#298Induction of mucosal tolerance to antigens
#299Induction of mucosal tolerance to antigens
#300Use of Inclusion Bodies as Therapeutic Agents